Efficacy of Nsp12 Inhibitors Against SARS-CoV-2 Omicron Variants
Recent clinical evaluations confirm that remdesivir and the oral candidate obeldesivir maintain potent antiviral activity against SARS-CoV-2 Omicron variants. By inhibiting the virus’s replication machinery, these therapies provide a critical ... Read More